04/21/2014 - 6:51pm

The introduction of store-brand products over the past decade changed the competitive landscape in most categories, with year-over-year growth outpacing national brands.

04/21/2014 - 2:07pm

ABC News will be hosting a live twitter chat focusing on pain management on Tuesday, April 22, at 1 p.m., as part of the news agency's next ABC News National Tweet Chat.

04/15/2014 - 10:26am

The Food and Drug Administration on Friday announced a meeting of the Nonprescription Drugs Advisory Committee on May 2 to discuss the potential switch of Merck's Singulair Allergy tablets.

04/07/2014 - 10:23am

Briggs Healthcare, a supplier to the hospital, pharmaceutical/DME and retail markets for 65 years, on Monday announced it is aligning its brands under the HealthSmart name as of summer 2014.

03/28/2014 - 7:22am

Fred's Super Dollar will be exiting a number of front-end categories — including footwear, televisions/home theater and select home furnishings — in an effort to expand seasonal, health, beauty, pharmacy and OTC, in line with reconfiguration plan strategies, Fred's CFO Jerry Shore told analysts Thursday.

03/26/2014 - 11:30am

Springtime allergy season may be delayed a few weeks this year, kicking into high gear in early April as opposed to late March due to a 2013-2014 winter characterized by extremely low temperatures and heavy snow storms.

03/26/2014 - 11:20am

Antibiotics are often inappropriately prescribed for adults with acute bronchitis. Clinical guidelines for treating adults with no co-morbidity do not indicate treatment with antibiotics.

03/26/2014 - 11:17am

The month of March came in like a lion, indeed, but not because of the weather. The month began with a roar as a group of the largest and most influential pharmacy associations and chains came together to form the Patient Access to Pharmacists’ Care Coalition, or PAPCC, in an effort to secure formal federal recognition of pharmacists as healthcare providers.

03/26/2014 - 11:15am

Early-stage Alzheimer’s disease, or AD, increasingly is the target of drug development efforts, but there are very few tools that measure the cognitive function of patients with the condition before the onset of dementia. Experts have concluded that it is best to treat patients prior to changes in cognition, before the symptoms of neurodegeneration appear. As a result, scientists have turned to biomarkers to provide some indication of whether AD is likely to develop.